Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Park, Chul-soo
ROSUZET-AMI, NCT04499859: Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI	Recruiting	4	3548	RoW	Ezetimibe 10mg + Rosuvastatin 5mg, Rosuzet 10/5 mg, Rosuvastatin 20mg, Crestor 20mg	Kiyuk Chang, MD,PhD	Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity	08/26	08/27
TAILORED-CHIP, NCT03465644: TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI	Active, not recruiting	4	2018	RoW	Tailored antithrombotic strategy, Conventional antithrombotic strategy	Duk-Woo Park, MD, CardioVascular Research Foundation, Korea	Coronary Stenoses	01/25	01/25
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention	Recruiting	N/A	20000	RoW		Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices	Coronary Artery Disease	04/37	04/37